Serious Gaming for Chemotherapy-induced Nausea and Vomiting

Recruiting now · Not applicable

Conditions studied: Neoplasms, Chemotherapy-induced Nausea and Vomiting

In brief

The purpose of this study is to examine the effectiveness of a technology-based intervention for managing nausea and vomiting in older adults with cancer. Participants will be randomized to either an intervention or control group. Outcomes such as symptom severity, quality of life, and resource use will be examined.

Key facts

Study ID

NCT05838638

Run by

University of Central Florida

People needed

610

Starts

2023-06-09

Expected to finish

2027-06-30

Last updated by the study team

2026-05-01

Who can join

Age: 60 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• age 60 or older
• newly diagnosed with cancer
• treatment with any chemotherapeutic agent of moderate or high emetic potential
• on a 2, 3 or 4 week treatment cycle
• proficient in English
• has a telephone

You may not qualify if…

• previous diagnosis and/or treatment for cancer
• end stage disease with less than 6 months to live
• visually or hearing impaired without corrective device

Where it is running

• Miller School of Medicine Sylvester Comp. Cancer Center — Miami, Florida, United States (enrolling)
• Orlando Health — Orlando, Florida, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.